Stocktoria
Compass Therapeutics, Inc. CMPX
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-11-13
Compass Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 4,713,247 | $10.3M | 2.64% |
| CITADEL ADVISORS LLC | 3,709,974 | $8.1M | 2.08% |
| AQR CAPITAL MANAGEMENT LLC | 3,509,137 | $7.7M | 1.97% |
| BlackRock Finance, Inc. | 6,613,637 | $6.6M | 3.71% |
| Point72 Asset Management, L.P. | 686,577 | $1.5M | 0.39% |
| TWO SIGMA INVESTMENTS, LP | 320,312 | $701,483 | 0.18% |
| D. E. Shaw & Co., Inc. | 204,487 | $447,827 | 0.11% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.